Petrelintide Phase 2 Results: A New Development in Amylin Peptide Research
Zealand Pharma reported positive Phase 2 topline results for petrelintide, an investigational long-acting amylin analog, in adults with overweight or obesity and type 2 diabetes.
By Zealand Pharma








